Gender Differences in Respiratory Care
Pulmonary Vascular Disease in Women
Anna R. Hemnes, MD
Faculty Presentations
MeiLan K. Han, MD MS
Anna R. Hemnes, MD
Discussion
Pulmonary Vascular Disease in Women by Anna R. Hemnes, MD
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
Clinical Classification
Fig. 04 -
PAH
Fig. 05 -
Sex and PAH
Fig. 06 -
Heritable PAH
Fig. 07 -
Other PAH Subtypes
Fig. 08 -
Non-Group 1 PH
Fig. 09 -
Outcomes
Fig. 10 -
Adult PAH Survival: U.S.
Fig. 11 -
PAH Survival: France
Fig. 12 -
Genders respond differently
Fig. 13 -
Three Classic Pathways
Fig. 14 -
Responses to PAH Therapies
Fig. 15 -
Sex-Based Differences
Fig. 16 -
Sex Hormone Modulation
Fig. 17 -
Anastrozole
Fig. 18 -
Treatment in CTEPH
Fig. 19 -
Women Worse Survival
Fig. 20 -
Pregnancy in PAH
Fig. 21 -
Summary
« Prev
16 / 21
Next »
Print This Page
Enlarge Figure
Could sex hormone modulation improve PAH?
References
[11]
Kawut et al, Am J Respir Crit Care Med, 2017
« Prev
16 / 21
Next »
Apply For Credit